These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 18707669)

  • 1. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
    Li L; Wang Z; Li R; Luo S; Sun X
    Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
    Córdoba S; Rodero L; Vivot W; Abrantes R; Davel G; Vitale RG
    Int J Antimicrob Agents; 2008 Feb; 31(2):171-4. PubMed ID: 18054469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of butenafine against ocular pathogenic filamentous fungi in vitro].
    Xu Y; Pang GR; Zhao DQ; Gao CW; Zhou LT; Sun ST; Wang BL; Chen ZJ
    Zhonghua Yan Ke Za Zhi; 2010 Jan; 46(1):38-42. PubMed ID: 20388321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
    Brooks DE; Andrew SE; Dillavou CL; Ellis G; Kubilis PS
    Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods.
    Iqbal NJ; Boey A; Park BJ; Brandt ME
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):348-50. PubMed ID: 18707841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
    Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.
    Pearce JW; Giuliano EA; Moore CP
    Vet Ophthalmol; 2009; 12(5):318-24. PubMed ID: 19751493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
    Marangon FB; Miller D; Giaconi JA; Alfonso EC
    Am J Ophthalmol; 2004 May; 137(5):820-5. PubMed ID: 15126145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A; Sancak B; Arikan S
    Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro fungistatic and fungicidal activities of silver sulfadiazine and natamycin on pathogenic fungi isolated from horses with keratomycosis.
    Betbeze CM; Wu CC; Krohne SG; Stiles J
    Am J Vet Res; 2006 Oct; 67(10):1788-93. PubMed ID: 17014335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro interactions between amphotericin B and other antifungal agents and rifampin against Fusarium spp.
    Spader TB; Venturini TP; Cavalheiro AS; Mahl CD; Mario DN; Lara VM; Santurio J; Alves SH
    Mycoses; 2011 Mar; 54(2):131-6. PubMed ID: 19780977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of phenylmercuric acetate against ocular pathogenic fungi.
    Xu Y; Zhao D; Gao C; Zhou L; Pang G; Sun S
    J Antimicrob Chemother; 2012 Aug; 67(8):1941-4. PubMed ID: 22514262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp.
    Venturini TP; Rossato L; Spader TB; Tronco-Alves GR; Azevedo MI; Weiler CB; Santurio JM; Alves SH
    Diagn Microbiol Infect Dis; 2011 Oct; 71(2):126-30. PubMed ID: 21840673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusarium spp. as agents of onychomycosis in immunocompetent hosts.
    Guilhermetti E; Takahachi G; Shinobu CS; Svidzinski TI
    Int J Dermatol; 2007 Aug; 46(8):822-6. PubMed ID: 17651164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
    Sarifakioglu E; Seçkin D; Demirbilek M; Can F
    Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
    Barchiesi F; Di Francesco LF; Compagnucci P; Arzeni D; Giacometti A; Scalise G
    J Antimicrob Chemother; 1998 Jan; 41(1):59-65. PubMed ID: 9511038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
    Vanathi M; Naik R; Sidhu N; Ahmed NH; Gupta N; Tandon R
    Indian J Ophthalmol; 2022 Dec; 70(12):4270-4283. PubMed ID: 36453329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.